U.S. market Closed. Opens in 1 day 8 hours 53 minutes

TTNP | Titan Pharmaceuticals, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-31
Revenue184.00K60.00K1.53M4.84M3.61M
Cost of Revenue1.91M196.00K199.00K472.00K1.29M
Gross Profit-1.73M-136.00K1.33M4.37M2.32M
Operating Expenses7.46M10.29M10.68M11.72M19.17M
Selling, General & Admin5.55M6.03M4.99M5.80M11.93M
Research & Development1.91M4.76M5.69M5.92M7.24M
Other Operating ExpensesN/A-497.00K-84.00K1.72M17.00K
Operating Income-7.28M-10.23M-9.35M-7.35M-16.84M
Other Expenses / Income1.71M29.00K578.00K-56.00K386.00K
Before Tax Income-5.57M-10.21M-8.78M-7.41M-16.46M
Income Tax ExpensesN/A-29.00K-662.00K13.32M-369.00K
Net Income-5.57M-10.18M-8.11M-20.73M-16.09M
Interest ExpensesN/AN/A1.00K769.00K967.00K
Basic Shares Outstanding752.00K671.70K486.50K188.65K1.28K
Diluted Shares Outstanding752.00K671.70K486.50K188.65K1.28K
EBITDA-7.17M-10.04M-9.13M-7.06M-6.28M
EBITDA Margin-3,894.02%-16,731.67%-598.49%-145.91%-173.89%
EBIT-5.57M-10.21M-8.78M-6.64M-15.49M
EBIT Margin-3,026.63%-17,010.00%-575.03%-137.21%-428.99%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙